Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02821481 · ClinicalTrials.gov registry record · NA
Beta-alanine and Elder Endurance
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT02821481: Completed NA study, sponsored by University of Miami.
NCT02821481 is a NA study that has completed, run by University of Miami. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02821481, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose for this study is to determine if beta-alanine supplementation combined with endurance-based resistance training can increase gains in muscular endurance to a greater extent than endurance-based resistance-training alone in older adults.
Primary Outcome
Short Physical Functional Performance test
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Beta-alanine
- BEHAVIORAL Muscular endurance exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02821481 record still lists
NCT02821481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02821481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02821481 about?
NCT02821481 is a clinical study titled "Beta-alanine and Elder Endurance". The purpose for this study is to determine if beta-alanine supplementation combined with endurance-based resistance training can increase gains in muscular endurance to a greater extent than endurance-based resistance-training alone in older adults.
What is the current status of trial NCT02821481?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-06. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02821481?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Beta-alanine (DIETARY_SUPPLEMENT), Muscular endurance exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02821481?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02821481's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia